Web Results


Feb 9, 2018 ... Oak Creek Investments, LLC v. Atlas Holdings LLC et al (1:18-cv-00023), Mississippi Northern District Court, Filed: 02/09/2018 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets.


May 25, 2016 ... SEC V. JSG CAPITAL INVESTMENTS, LLC, ET AL. COMPLAINT. 1. 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. Plaintiff Securities and Exchange Commission (“Commission”) alleges: SUMMARY OF THE ACTION. 1. The Commission brings this action to halt ...


JOHNSON v. BULLHEAD INVESTMENTS, LLC et al, No. 1:2009cv00639 - Document 29 (M.D.N.C. 2010) case opinion from the Middle District of North Carolina U.S. Federal District Court.


Jul 17, 2015 ... For couples attending in vitro fertilization (IVF) clinics, intracytoplasmic sperm injection (ICSI) is a widely used treatment option (Palermo et al., 1992; Johnson et al., 2013) that is remarkably successful, compared with conventional IVF treatments, for treating many cases of male factor infertility (Palermo et al.


Dec 16, 2016 ... Nakano et al. suggested that their UVR-emitting light therapy acted through a vitamin D-dependent pathway to suppress signs of metabolic disturbance. ..... Additionally, in a small cross-sectional study (n = 307) of Indian men (aged 40– 60 years, mainly type V skin), there was no significant relationship ...


et al., 2013a, b; Kashir et al., 2014). In this study, we have investigated whether recombinant human PLCz protein can be used to rescue cases of failed fertilization or to improve poor development rates after ICSI. We use a mouse model of failed oocyte activation after ICSI by applying mild heat treatment of mouse sperm.


Such Ca2+ oscillations have been observed in human and mouse oocytes after in vitro fertilization and ICSI (Sato et al., 1999). Such Ca2+ oscillations are both necessary and sufficient for oocyte activation (Kurokawa et al.,. 2004) and may influence subsequent embryo development (Ducibella et al., 2002; Yu et al., 2008).


Jul 1, 2001 ... Looking at a pharmacokinetic analysis of the disposition of AZT (Takasawa et al., 1997a) and new quinolone antibiotics (Ooie et al., 1997) in the brain .... These constructs were introduced into LLC-PK1 cells by lipofection with LipofectAMINE (Life Technologies) according to the manufacturer's protocols, ...